An Extension Study of LON002 in Patients With Cancer
NCT02390986
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumours
Interventions
DRUG:
LON002
Sponsor
LondonPharma Ltd.